160 related articles for article (PubMed ID: 11418641)
1. Enhancement of CD8+ T cell responses by ICOS/B7h costimulation.
Wallin JJ; Liang L; Bakardjiev A; Sha WC
J Immunol; 2001 Jul; 167(1):132-9. PubMed ID: 11418641
[TBL] [Abstract][Full Text] [Related]
2. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
[TBL] [Abstract][Full Text] [Related]
3. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.
Harada H; Salama AD; Sho M; Izawa A; Sandner SE; Ito T; Akiba H; Yagita H; Sharpe AH; Freeman GJ; Sayegh MH
J Clin Invest; 2003 Jul; 112(2):234-43. PubMed ID: 12865411
[TBL] [Abstract][Full Text] [Related]
4. ICOS-induced B7h shedding on B cells is inhibited by TLR7/8 and TLR9.
Logue EC; Bakkour S; Murphy MM; Nolla H; Sha WC
J Immunol; 2006 Aug; 177(4):2356-64. PubMed ID: 16887997
[TBL] [Abstract][Full Text] [Related]
5. B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo.
Liu X; Bai XF; Wen J; Gao JX; Liu J; Lu P; Wang Y; Zheng P; Liu Y
J Exp Med; 2001 Nov; 194(9):1339-48. PubMed ID: 11696598
[TBL] [Abstract][Full Text] [Related]
6. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection.
Kashizuka H; Sho M; Nomi T; Ikeda N; Kuzumoto Y; Akashi S; Tsurui Y; Mizuno T; Kanehiro H; Yagita H; Nakajima Y; Sayegh MH
Transplantation; 2005 May; 79(9):1045-50. PubMed ID: 15880041
[TBL] [Abstract][Full Text] [Related]
7. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells.
Ogasawara K; Yoshinaga SK; Lanier LL
J Immunol; 2002 Oct; 169(7):3676-85. PubMed ID: 12244160
[TBL] [Abstract][Full Text] [Related]
8. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.
Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R
J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling.
Liang L; Porter EM; Sha WC
J Exp Med; 2002 Jul; 196(1):97-108. PubMed ID: 12093874
[TBL] [Abstract][Full Text] [Related]
10. B7h-expressing dendritic cells and plasma B cells mediate distinct outcomes of ICOS costimulation in T cell-dependent antibody responses.
Larimore K; Liang L; Bakkour S; Sha WC
BMC Immunol; 2012 Jun; 13():29. PubMed ID: 22686515
[TBL] [Abstract][Full Text] [Related]
11. CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors.
Hanson HL; Kang SS; Norian LA; Matsui K; O'Mara LA; Allen PM
J Immunol; 2004 Apr; 172(7):4215-24. PubMed ID: 15034034
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.
Iwai H; Kozono Y; Hirose S; Akiba H; Yagita H; Okumura K; Kohsaka H; Miyasaka N; Azuma M
J Immunol; 2002 Oct; 169(8):4332-9. PubMed ID: 12370365
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.
Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Yagita H; Turka LA; Sayegh MH
Am J Transplant; 2005 Jan; 5(1):31-9. PubMed ID: 15636609
[TBL] [Abstract][Full Text] [Related]
15. B7h is required for T cell activation, differentiation, and effector function.
Nurieva RI; Mai XM; Forbush K; Bevan MJ; Dong C
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14163-8. PubMed ID: 14615582
[TBL] [Abstract][Full Text] [Related]
16. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of T-cell expansion caused by inducible costimulator/B7h costimulation blockade in direct allorecognition pathway.
Du JF; Li QY; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
Transplant Proc; 2011 Dec; 43(10):3960-3. PubMed ID: 22172879
[TBL] [Abstract][Full Text] [Related]
18. A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo.
Izawa A; Yamaura K; Albin MJ; Jurewicz M; Tanaka K; Clarkson MR; Ueno T; Habicht A; Freeman GJ; Yagita H; Abdi R; Pearson T; Greiner DL; Sayegh MH; Najafian N
J Immunol; 2007 Jul; 179(2):786-96. PubMed ID: 17617568
[TBL] [Abstract][Full Text] [Related]
19. B7h (ICOS-L) maintains tolerance at the fetomaternal interface.
Riella LV; Dada S; Chabtini L; Smith B; Huang L; Dakle P; Mfarrej B; D'Addio F; Adams LT; Kochupurakkal N; Vergani A; Fiorina P; Mellor AL; Sharpe AH; Yagita H; Guleria I
Am J Pathol; 2013 Jun; 182(6):2204-13. PubMed ID: 23578385
[TBL] [Abstract][Full Text] [Related]
20. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis.
Iwai H; Abe M; Hirose S; Tsushima F; Tezuka K; Akiba H; Yagita H; Okumura K; Kohsaka H; Miyasaka N; Azuma M
J Immunol; 2003 Sep; 171(6):2848-54. PubMed ID: 12960306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
